Log In
Print this Print this

human plasma-derived plasminogen

  Manage Alerts
Collapse Summary General Information
Company ProMetic Life Sciences Inc.
DescriptionHuman plasma-derived purified plasminogen formulated for IV use
Molecular Target
Mechanism of Action 
Therapeutic ModalityBiologic: Protein
Latest Stage of DevelopmentPhase II/III
Standard Indication Hematology (unspecified)
Indication DetailsTreat plasminogen deficiency (hypoplasminogenemia)
Regulatory Designation U.S. - Fast Track (Treat plasminogen deficiency (hypoplasminogenemia));
U.S. - Orphan Drug (Treat plasminogen deficiency (hypoplasminogenemia));
EU - Orphan Drug (Treat plasminogen deficiency (hypoplasminogenemia))

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
 Deals Details
Get a free BioCentury trial today